Drugs Made in America Ac-RTSDMAARPreferred / convertible
13F holders, Q1 2026 (March 31)35holders +3
5new positions
3sold out
$0.06avg. 13F price*
At the end of Q1 2026, 35 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings, up 3 from Q4 2025. 5 opened new positions and 3 sold out. The largest holders were Polar Asset Management Partners Inc. ($114K), Hudson Bay Capital Management LP ($94K) and Highbridge Capital Management LLC ($63K).
- Company
- Drugs Made in America Ac-RTS
- CUSIP
- G2847J112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $19K |
| Exits | 3 | $340K |
All 13F filers, Q4 2025 → Q1 2026: 998,952 shares bought and 3,508,193 shares sold, net −2,509,241 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Polar Asset Management Partners Inc. | — | No change | 1,900,000 | $114K |
| Hudson Bay Capital Management LP | — | Reduce -5.5% | 1,701,546 | $94K |
| Highbridge Capital Management LLC | — | Add +2.0% | 1,044,319 | $63K |
| Mangrove Partners Im, LLC | — | No change | 850,000 | $51K |
| Linden Advisors LP | — | No change | 850,000 | $49K |
| Clear Street Group Inc. | — | Add +13.8% | 711,917 | $43K |
| Boothbay Fund Management, LLC | — | Add +22.0% | 695,227 | $42K |
| Wolverine Asset Management LLC | — | Add +23.1% | 693,136 | $42K |
| Toronto Dominion Bank | — | Reduce -31.2% | 690,000 | $41K |
| LMR Partners LLP | — | No change | 500,000 | $30K |
| Westchester Capital Management, LLC | — | No change | 500,000 | $28K |
| Shaolin Capital Management LLC | — | Reduce -25.0% | 450,000 | $27K |
| Rivernorth Capital Management, LLC | — | No change | 417,998 | $25K |
| Whitebox Advisors LLC | — | No change | 400,000 | $24K |
| RLH Capital LLC | — | — | 399,391 | $24K |
| Alpine Global Management, LLC | — | No change | 362,500 | $22K |
| AQR Arbitrage LLC | — | Reduce -2.1% | 372,322 | $21K |
| Glazer Capital, LLC | — | Reduce -44.6% | 297,475 | $18K |
| Aristeia Capital, L.L.C. | — | Reduce -70.0% | 264,168 | $16K |
| CSS LLC | — | No change | 31,250 | $15K |
| Quarry LP | — | Add +149.4% | 249,391 | $15K |
| Radcliffe Capital Management, L.P. | — | Reduce -28.8% | 231,551 | $13K |
| Context Capital Management, LLC | — | Reduce -19.6% | 201,016 | $12K |
| Meteora Capital, LLC | — | Add +9029.0% | 182,581 | $11K |
| BNP Paribas Financial Markets | — | No change | 119,686 | $7K |
| Commonwealth of Pennsylvania Public School Empls Retrmt SYS | — | New | 117,544 | $7K |
| DLD Asset Management, LP | — | No change | 101,594 | $6K |
| Verition Fund Management LLC | — | Reduce -0.8% | 99,200 | $5K |
| Periscope Capital Inc. | — | No change | 75,000 | $5K |
| Lineage Point Capital LP | — | New | 50,000 | $3K |
| Gabelli Funds LLC | — | New | 49,300 | $3K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | New | 48,100 | $3K |
| Readystate Asset Management LP | — | No change | 50,000 | $3K |
| Bulldog Investors, LLP | — | Reduce -66.7% | 43,364 | $3K |
| StoneX Group Inc. | — | New | 42,120 | $3K |
"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.